Porpiglia Francesco, Russo Filippo, Manfredi Matteo, Mele Fabrizio, Fiori Cristian, Regge Daniele
Division of Urology, University of Turin, San Luigi Gonzaga Hospital, Orbassano, Turin, Italy.
Radiology Unit Institute for Cancer Research and Treatment, Candiolo, Turin, Italy.
Int Braz J Urol. 2015 Jan-Feb;41(1):124-33. doi: 10.1590/S1677-5538.IBJU.2015.01.17.
The aim of the study was to analyse and compare the ability of multiparametric magnetic resonance imaging (mp-MRI) and prostate biopsy (PB) to correctly identify tumor foci in patients undergoing radical prostatectomy (RP) for prostate cancer (PCa).
157 patients with clinically localised PCa with a PSA <10 ng/ mL and a negative DRE diagnosed on the first (12 samples, Group A) or second (18 samples, Group B) PB were enrolled at our institution. All patients underwent mp-MRI with T2-weighted images, diffusion-weighted imaging, dynamic contrast enhanced-MRI prior to RP. A map of comparison describing each positive biopsy sample was created for each patient, with each tumor focus shown on the MRI and each lesion present on the definitive histological examination in order to compare tumor detection and location. The sensitivity of mp-MRI and PB for diagnosis was compared using Student's t-test. The ability of the two exams to detect the prevalence of Gleason pattern 4 in the identified lesions was compared using a chi-square test.
Overall sensitivity of PB and mp-MRI to identify tumor lesion was 59.4% and 78.9%, respectively (p<0.0001). PB missed 144/355 lesions, 59 of which (16.6%) were significant. mp-MRI missed 75/355 lesions, 12 of which (3.4%) were significant. No lesions with a GS≥8 were missed. Sensitivity of PB and mp-MRI to detect the prevalence of Gleason pattern 4 was 88.2% and 97.4%, respectively.
mp-MRI seems to identify more tumor lesions than PB and to provide more information concerning tumor characteristics.
本研究旨在分析和比较多参数磁共振成像(mp-MRI)和前列腺穿刺活检(PB)在接受前列腺癌(PCa)根治性前列腺切除术(RP)患者中正确识别肿瘤病灶的能力。
157例临床局限性PCa患者,其前列腺特异性抗原(PSA)<10 ng/mL且直肠指检(DRE)阴性,在我们机构接受了首次(12例样本,A组)或第二次(18例样本,B组)PB检查。所有患者在RP术前均接受了具有T2加权成像、扩散加权成像、动态对比增强MRI的mp-MRI检查。为每位患者创建了一张描述每个阳性活检样本的对比图,将MRI上显示的每个肿瘤病灶与最终组织学检查中存在的每个病变进行对比,以比较肿瘤的检测和定位情况。使用学生t检验比较mp-MRI和PB诊断的敏感性。使用卡方检验比较两种检查在已识别病变中检测 Gleason 4级模式患病率的能力。
PB和mp-MRI识别肿瘤病变的总体敏感性分别为59.4%和78.9%(p<0.0001)。PB漏诊了144/355个病变,其中59个(16.6%)为显著病变。mp-MRI漏诊了75/355个病变,其中12个(3.4%)为显著病变。没有漏诊 Gleason评分(GS)≥8的病变。PB和mp-MRI检测Gleason 4级模式患病率的敏感性分别为88.2%和97.4%。
mp-MRI似乎比PB能识别更多的肿瘤病变,并能提供更多关于肿瘤特征的信息。